LIF-dependent JAK3 activation is not essential for retinal degeneration

Journal of Neurochemistry

Volumn 113, Issue 5, 2010, Pages 1210-1220

  Lange, Christina ^a   Thiersch, Markus ^a   Samardzija, Marijana ^a   Bürgi, Sandra ^a   Joly, Sandrine ^a   Grimm, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

JAK STAT signaling; Janus kinase 3; Leukemia inhibitory factor; Neuroprotection; Retinal degeneration

Indexed keywords

JANUS KINASE 3; LEUKEMIA INHIBITORY FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA DEGENERATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; ENZYME ACTIVATION; EYE; FLUORESCENT ANTIBODY TECHNIQUE; INJECTIONS; JANUS KINASE 3; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; PHOTORECEPTOR CELLS, VERTEBRATE; RECOMBINANT PROTEINS; RETINA; RETINAL DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION;

MUS;

EID: 77951898845     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06686.x     Document Type: Article

References (41)

1. Bowes C., Li T., Danciger M., Baxter L. C., Applebury M. L. Farber D. B. (1990) Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 347, 677 680. (Pubitemid 20356246)
2. Burgi S., Samardzija M. Grimm C. (2009) Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration. Mol. Vis. 15, 1631 1637.
3. Chang B., Hawes N. L., Pardue M. T. et al. (2007) Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vision Res. 47, 624 633. (Pubitemid 46240231)
4. Ghoreschi K., Laurence A. O'Shea J. J. (2009) Janus kinases in immune cell signaling. Immunol. Rev. 228, 273 287.
5. Grimm C., Wenzel A., Hafezi F. Reme C. E. (2000a) Gene expression in the mouse retina: the effect of damaging light. Mol. Vis. 6, 252 260.
6. Grimm C., Wenzel A., Hafezi F., Yu S., Redmond T. M. Reme C. E. (2000b) Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat. Genet. 25, 63 66. (Pubitemid 30257038)
7. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M. Reme C. E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718 724. (Pubitemid 34778725)
8. Jin M., Li S., Moghrabi W. N., Sun H. Travis G. H. (2005) Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 122, 449 459. (Pubitemid 41127145)
9. Joly S., Lange C., Thiersch M., Samardzija M. Grimm C. (2008) Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J. Neurosci. 28, 13765 13774.
10. Joly S., Samardzija M., Wenzel A., Thiersch M. Grimm C. (2009a) Nonessential role of beta3 and beta5 integrin subunits for efficient clearance of cellular debris after light-induced photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 50, 1423 1432.
11. Joly S., Francke M., Ulbricht E. et al. (2009b) Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am. J. Pathol. 174, 2310 2323.
12. Kerr B. J. Patterson P. H. (2004) Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp. Neurol. 188, 391 407.
13. Lamb T. D. Pugh Jr. E. N. (2004) Dark adaptation and the retinoid cycle of vision. Prog. Retin. Eye Res. 23, 307 380.
14. Leonard W. J. O'Shea J. J. (1998) Jaks and STATs: biological implications. Annu. Rev. Immunol. 16, 293 322.
15. Linker R. A., Kruse N., Israel S. et al. (2008) Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. J. Immunol. 180, 2204 2213.
16. Moiseyev G., Chen Y., Takahashi Y., Wu B. X. Ma J. X. (2005) RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc. Natl Acad. Sci. USA 102, 12413 12418. (Pubitemid 41266373)
17. Naash M. I., Hollyfield J. G., al-Ubaidi M. R. Baehr W. (1993) Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl Acad. Sci. USA 90, 5499 5503. (Pubitemid 23176188)
18. Ng T. F. Streilein J. W. (2001) Light-induced migration of retinal microglia into the subretinal space. Invest. Ophthalmol. Vis. Sci. 42, 3301 3310.
19. Noell W. K. Albrecht R. (1971) Irreversible effects on visible light on the retina: role of vitamin A. Science 172, 76 79.
20. O'Shea J. J., Gadina M. Schreiber R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak&Stat pathway. Cell 109 (Suppl S121 S131. (Pubitemid 34457857)
21. Rawlings J. S., Rosler K. M. Harrison D. A. (2004) The JAK&STAT signaling pathway. J. Cell Sci. 117, 1281 1283.
22. Redmond T. M., Poliakov E., Yu S., Tsai J. Y., Lu Z. Gentleman S. (2005) Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc. Natl Acad. Sci. USA 102, 13658 13663. (Pubitemid 41420904)
23. Reme C. E., Grimm C., Hafezi F., Marti A. Wenzel A. (1998) Apoptotic cell death in retinal degenerations. Prog. Retin. Eye Res. 17, 443 464. (Pubitemid 28432977)
24. Rodig S. J., Meraz M. A., White J. M. et al. (1998) Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373 383.
25. Rohrer B., Demos C., Frigg R. Grimm C. (2007) Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse. Exp. Eye Res. 84, 82 91. (Pubitemid 44803019)
26. Samardzija M., Wenzel A., Naash M., Reme C. E. Grimm C. (2006a) Rpe65 as a modifier gene for inherited retinal degeneration. Eur. J. Neurosci. 23, 1028 1034. (Pubitemid 43344697)
27. Samardzija M., Wenzel A., Aufenberg S., Thiersch M., Reme C. Grimm C. (2006b) Differential role of Jak-STAT signaling in retinal degenerations. FASEB J. 20, 2411 2413. (Pubitemid 44953843)
28. Samardzija M., von Lintig J., Tanimoto N., Oberhauser V., Thiersch M., Reme C. E., Seeliger M., Grimm C. Wenzel A. (2008) R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal. Hum. Mol. Genet. 17, 281 292.
29. Schindler C., Levy D. E. Decker T. (2007) JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059 20063. (Pubitemid 47099977)
30. Soldevila G., Licona I., Salgado A., Ramirez M., Chavez R. Garcia-Zepeda E. (2004) Impaired chemokine-induced migration during T-cell development in the absence of Jak 3. Immunology 112 : 191 200. (Pubitemid 38703565)
31. Streilein J. W. (2003) Ocular immune privilege: The eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74, 179 185.
32. Sugiura S., Lahav R., Han J., Kou S. Y., Banner L. R., de Pablo F. Patterson P. H. (2000) Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur. J. Neurosci. 12, 457 466. (Pubitemid 30142747)
33. Taylor A. W. (2009) Ocular immune privilege. Eye (Lond) 23, 1885 1889.
34. Thomis D. C. Berg L. J. (1997) The role of Jak3 in lymphoid development, activation, and signaling. Curr. Opin. Immunol. 9, 541 547. (Pubitemid 27392852)
35. Thomis D. C., Gurniak C. B., Tivol E., Sharpe A. H. Berg L. J. (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270 : 794 797.
36. Ueki Y., Wang J., Chollangi S. Ash J. D. (2008) STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage. J. Neurochem. 105, 784 796. (Pubitemid 351562724)
37. Verbsky J. W., Bach E. A., Fang Y. F., Yang L., Randolph D. A. Fields L. E. (1996) Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J. Biol. Chem. 271, 13976 13980. (Pubitemid 26190287)
38. Villa A., Sironi M., Macchi P., Matteucci C., Notarangelo L. D., Vezzoni P. Mantovani A. (1996) Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene. Blood 88 : 817 823. (Pubitemid 26333301)
39. Watford W. T. O'Shea J. J. (2006) Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity 25, 695 697.
40. Wenzel A., Reme C. E., Williams T. P., Hafezi F. Grimm C. (2001) The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J. Neurosci. 21, 53 58. (Pubitemid 32098725)
41. Wenzel A., Grimm C., Samardzija M. Reme C. E. (2005) Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog. Retin. Eye Res. 24, 275 306. (Pubitemid 40021788)